DNA Drug Design for Cancer Therapy
Journal:
Current Pharmaceutical Design
Volume:
11
Page:
2811-2823
Author(s):
Y. S. Cho-Chung
Oligonucleotides as Anticancer Agents: From the Benchside to the Clinic and Beyond
Journal:
Current Pharmaceutical Design
Volume:
11
Page:
2825-2840
Author(s):
F. M. Coppelli and J. R. Grandis
Rational Drug Design of G-Quartet DNA as Anti-Cancer Agents
Journal:
Current Pharmaceutical Design
Volume:
11
Page:
2841-2854
Author(s):
N. Jing, W. Sha, Y. Li, W. Xiong and D. J. Tweardy
Targeting Transcription Factors for Cancer Therapy
Journal:
Current Pharmaceutical Design
Volume:
11
Page:
2873-2887
Author(s):
M. S. Redell and D. J. Tweardy
Activated Surfaces for Laser Desorption Mass Spectrometry: Application for Peptide and Protein Analysis
Journal:
Current Pharmaceutical Design
Volume:
11
Page:
2559-2576
Author(s):
C. Afonso, N. Budimir, F. Fournier and J- C. Tabet
Application of MALDI-TOF Mass Spectrometry in Screening and Diagnostic Research
Journal:
Current Pharmaceutical Design
Volume:
11
Page:
2577-2591
Author(s):
W. Pusch and M. Kostrzewa
Antiproliferative Efficacy of Angiotensin II Receptor Blockers in Prostate Cancer
Journal:
Current Cancer Drug Targets
Volume:
5
Page:
307-323
Author(s):
Hiroji Uemura, Noboru Nakaigawa, Hitoshi Ishiguro and Yoshinobu Kubota
Inflammation and Cancer: When NF-κB Amalgamates the Perilous Partnership
Journal:
Current Cancer Drug Targets
Volume:
5
Page:
325-344
Author(s):
Marina A. Dobrovolskaia and Serguei V. Kozlov
Molecular Targets from VHL Studies into the Oxygen-Sensing Pathway
Journal:
Current Cancer Drug Targets
Volume:
5
Page:
345-356
Author(s):
M. A. Maynard and M. Ohh
Synthesis and in Vitro Anti-Proliferative Activity of Racemic Trifluoro-Casodex® (Bicalutamide)
Journal:
Letters in Organic Chemistry
Volume:
2
Page:
447-449
Author(s):
M. Sani, F. Viani, M. Binda, N. Zaffaroni and M. Zanda